These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 28164648)

  • 21. Significance of fully automated tests for the diagnosis of antiphospholipid syndrome.
    Oku K; Amengual O; Kato M; Bohgaki T; Horita T; Yasuda S; Sakamoto N; Ieko M; Norman GL; Atsumi T
    Thromb Res; 2016 Oct; 146():1-6. PubMed ID: 27552227
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiphospholipid antibody ELISAs: survey on the performance of clinical laboratories assessed by using lyophilized affinity-purified IgG with anticardiolipin and anti-beta2-Glycoprotein I activity.
    Pengo V; Biasiolo A; Bison E; Chantarangkul V; Tripodi A;
    Thromb Res; 2007; 120(1):127-33. PubMed ID: 17020782
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IgM, but not IgA rheumatoid factor interferes with anti-cardiolipin and antiβ2 glycoprotein I measurements: a quantitative analysis.
    Lakos G; Teodorescu M
    Lupus; 2011 May; 20(6):614-9. PubMed ID: 21436214
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical significance of anti-domain 1 β2-glycoprotein I antibodies in antiphospholipid syndrome.
    Iwaniec T; Kaczor MP; Celińska-Löwenhoff M; Polański S; Musiał J
    Thromb Res; 2017 May; 153():90-94. PubMed ID: 28363116
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical utility of automated chemiluminescent antiphospholipid antibody assay.
    Iwaniec T; Kaczor MP; Celińska-Löwenhoff M; Polański S; Musiał J
    Thromb Res; 2015 Nov; 136(5):1033-9. PubMed ID: 26376037
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Revisiting the Phadia/EliA cut-off values for anticardiolipin and anti-β2-glycoprotein I antibodies: a systematic evaluation according to the guidelines.
    Bor MV; Jacobsen IS; Gram JB; Sidelmann JJ
    Lupus; 2018 Aug; 27(9):1446-1454. PubMed ID: 29848159
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thrombotic risk assessment and analytical performance of the chemiluminescent analyzer IDS-iSYS for the detection of anti-cardiolipin and anti-beta 2 glycoprotein I autoantibodies.
    Salma N; Julie L; Boutahar B; Sylvie LN; Eleonore B; Fabien LN; Elisabeth P; Sandrine JJ; Francis C; Sophie H; Yves R
    Clin Immunol; 2018 Sep; 194():92-99. PubMed ID: 30017909
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Two Novel Technologies for the Detection of Anti-cardiolipin and Anti β2-Glycoprotein Antibodies in the Real Life: Chemiluminescent in Comparison to the Addressable Laser Bead Immunoassays.
    Grossi V; Infantino M; Benucci M; Li Gobbi F; Bandinelli F; Damiani A; Bodio C; Borghi MO; Mahler M; Aure MA; Bentow C; Manfredi M
    Immunol Invest; 2020 Feb; 49(1-2):58-68. PubMed ID: 31401900
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of Anti-Cardiolipin and Anti-β2glycoprotein I Antibodies Differs between Platforms without Influence on Association with Clinical Symptoms.
    Chayoua W; Kelchtermans H; Moore GW; Gris JC; Musial J; Wahl D; Zuily S; Gianniello F; Fontana P; Remijn J; Urbanus RT; de Laat B; Devreese KMJ
    Thromb Haemost; 2019 May; 119(5):797-806. PubMed ID: 30822809
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The (non-)sense of detecting anti-cardiolipin and anti-β2glycoprotein I IgM antibodies in the antiphospholipid syndrome.
    Chayoua W; Kelchtermans H; Gris JC; Moore GW; Musiał J; Wahl D; de Groot PG; de Laat B; Devreese KMJ
    J Thromb Haemost; 2020 Jan; 18(1):169-179. PubMed ID: 31519058
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-β2 glycoprotein I antibodies and pregnancy outcome in antiphospholipid syndrome.
    Liu XL; Xiao J; Zhu F
    Acta Obstet Gynecol Scand; 2013 Feb; 92(2):234-7. PubMed ID: 23157457
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Solid Phase Assays for Antiphospholipid Antibodies.
    Devreese KMJ
    Semin Thromb Hemost; 2022 Sep; 48(6):661-671. PubMed ID: 35675831
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical performance of automated chemiluminescent methods for anticardiolipin and anti-β2-glycoprotein I antibodies detection in a large cohort of Chinese patients with antiphospholipid syndrome.
    Wan LY; Gu JY; Liu TT; Hu QY; Jia JC; Teng JL; Sun Y; Liu HL; Cheng XB; Ye JN; Su YT; Wu XY; Chi HH; Zhou ZC; Wang ZH; Zhou JF; Norman GL; Dai J; Yang CD; Shi H
    Int J Lab Hematol; 2020 Apr; 42(2):206-213. PubMed ID: 31958215
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Associations Among Antiphospholipid Antibody Types, Isotypes, and Titers: An AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Study.
    Gkrouzman E; Willis R; Andrade D; Tektonidou MG; Pengo V; Ruiz-Irastorza G; Belmont HM; Fortin PR; Gerosa M; Signorelli F; Atsumi T; Branch DW; Nalli C; Rodriguez-Almaraz E; Petri MA; Cervera R; Knight JS; Efthymiou M; Cohen H; Bertolaccini ML; Erkan D; Roubey R;
    Lab Invest; 2023 Jun; 103(6):100147. PubMed ID: 37044248
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Performance Evaluation of Antiphospholipid Antibodies on INOVA Quanta Flash System.
    Liang EY; Ke PF; Li GH; Huang H; Huang WJ; Liu RP; Huang XZ; He M
    Clin Lab; 2021 Apr; 67(4):. PubMed ID: 33865256
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of diagnostic methods for the detection of anticardiolipin and anti-βeta
    Martins TB; Heikal N; Miller J; Willis R; Schmidt RL; Tebo AE
    Clin Chim Acta; 2018 Oct; 485():7-13. PubMed ID: 29883633
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phospholipid autoantibodies and the antiphospholipid antibody syndrome: diagnostic accuracy of 23 methods studied by variation in ROC curves with number of clinical manifestations.
    Wasmuth JC; Oliver y Miñarro D; Homrighausen A; Leifeld L; Rockstroh JK; Sauerbruch T; Spengler U
    Clin Chem; 2002 Jul; 48(7):1004-10. PubMed ID: 12089167
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
    J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antiphospholipid antibodies: evaluation of the thrombotic risk.
    Devreese KM
    Thromb Res; 2012 Oct; 130 Suppl 1():S37-40. PubMed ID: 23026657
    [TBL] [Abstract][Full Text] [Related]  

  • 40. How to Interpret Antiphospholipid Laboratory Tests.
    Devreese KMJ
    Curr Rheumatol Rep; 2020 Jun; 22(8):38. PubMed ID: 32562091
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.